Portfolio company
Corvivo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Corvivo Cardiovascular develops regenerative medical devices for surgeons to repair damaged heart valves and cardiac tissue in adult and paediatric patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
CorWave
This company develops implantable heart pumps with membrane technology to provide pulsatile blood flow for patients suffering from advanced heart failure.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
CoreValve SA
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
Avery Therapeutics
Avery Therapeutics develops tissue-engineered heart grafts to treat patients with chronic heart failure.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
